About Indo US Bio-Tech Limited

Indo US Bio-Tech Limited is an agro-based company focused on research, development and marketing of seeds, with a track record highlighted by the company’s Twenty-first (21st) Annual Report for the year ended March 31, 2025. The Board presented standalone audited financial statements for the period, underscoring the company’s reporting as a standalone entity for the year. Headquartered at 309, Shanti Mall, Satadhar Char Rasta, Opp. Navrang Tower, Sola Road, Ahmedabad-380061, Gujarat, the company’s registered office anchors a nationwide dealer footprint.

Under the stewardship of its Managing Director, the company expanded full-fledged R&D activities and released promising varieties in vegetables and crops, supported by a strong marketing network of more than 5,500 active dealers across the country. This network enables sales of the company’s products throughout India, reflecting the company’s focus on the domestic market. The Directors’ Report confirms that foreign exchange information is not applicable as the company is an agro-based industry, and there was no foreign exchange gain during the year, further signalling a domestic orientation.

Subsidiaries: The Annual Report presents standalone financials and does not state the number of subsidiaries for the year ended March 31, 2025.

Key Milestones of Indo US Bio-Tech Limited

Key milestones achieved include the company’s migration from the SME Platform of BSE to the Main Board of both BSE and NSE—trading approvals were received on September 26, 2024 and September 25, 2024, respectively. The year also marked the continued strengthening of governance processes, as reflected in statutory certifications and board actions.

Indo US Bio-Tech Limited Business Verticals and Geographical Presence 

Indo US Bio-Tech Limited focuses on the development and marketing of seeds backed by full-fledged R&D, with varieties released in vegetables and crops. The company sells through a nationwide network of more than 5,500 dealers across India. The company’s operations are focused on the domestic market, with the registered office in Ahmedabad, Gujarat.

Indo US Bio-Tech Limited Business Segment

The company focuses on the development and marketing of seeds backed by full-fledged R&D, with varieties released in vegetables and crops. Indo US Bio-Tech Limited sells through a nationwide network of more than 5,500 dealers across India. The registered office is at 309, Shanti Mall, Satadhar Char Rasta, Opp. Navrang Tower, Sola Road, Ahmedabad-380061, Gujarat.

Indo US Bio-Tech Limited Key Management

• Jagdish D. Ajudia – Chairman & Managing Director
• Malti J. Ajudia – Whole-time Director
• Priyanka J. Ajudia – Director
• Ritaben Nileshbhai Kikani – Director
• Shilpa Chetanbhai Thumar – Director
• Nehaben Sachinbhai Patel – Director
• Dimpy Joshi – Company Secretary & Compliance Officer

Latest Updates on Indo US Bio-Tech Limited

• Migration to Main Boards: The company received trading approvals for migration from the BSE SME Platform to the Main Board of both BSE and NSE on September 26, 2024 and September 25, 2024, respectively, marking a key capital markets milestone.
• Leadership continuity: The Board proposed the re-appointment of Mr. Jagdish Ajudiya (DIN: 01745951) as Managing Director for a five-year term from November 23, 2025 to November 22, 2030, noting his contribution in building R&D capabilities and a pan-India marketing network of 5,500+ dealers.
• Strengthening assurance functions: CA Raj Shah (Membership No. 166492; FRN: 141020W) was appointed as Internal Auditor, and Amrish Gandhi & Associates (FCS: 8193; COP: 5656) was appointed as Secretarial Auditor during the year.
• Corporate governance: A Corporate Governance Compliance Certificate dated August 26, 2025 certified compliance with the conditions stipulated by SEBI (LODR) Regulations, 2015.
• Capital structure and committees: The company increased its authorised share capital through a postal ballot in November 2024 and reconstituted board committees on November 27, 2024, as recorded in the Secretarial Audit Report.
• Compliance observations: The Secretarial Audit noted that the SDD (Structured Digital Database) software was not properly updated and recorded a non-compliance of Regulation 18(1) of SEBI (LODR) 2015 for which a penalty was imposed and paid; a waiver application was filed with BSE & NSE.